280 related articles for article (PubMed ID: 16088931)
21. Malignant melanoma: management guidelines.
Brozena SJ; Waterman G; Fenske NA
Geriatrics; 1990 Jun; 45(6):55-8, 61-2. PubMed ID: 2187751
[TBL] [Abstract][Full Text] [Related]
22. Update of diagnostic and prognostic markers in cutaneous malignant melanoma.
Reed JA; Albino AP
Clin Lab Med; 2000 Dec; 20(4):817-38. PubMed ID: 11221516
[TBL] [Abstract][Full Text] [Related]
23. [Malignant melanoma--diagnosis and treatment].
Jacobsen KD; Fosså SD; Aamdal S
Tidsskr Nor Laegeforen; 2006 Nov; 126(23):3094-7. PubMed ID: 17160112
[TBL] [Abstract][Full Text] [Related]
24. Melanoma gene expression and clinical course.
Vourc'h-Jourdain M; Volteau C; Nguyen JM; Khammari A; Dreno B
Arch Dermatol Res; 2009 Oct; 301(9):673-9. PubMed ID: 19326132
[TBL] [Abstract][Full Text] [Related]
25. Interpretation, accuracy and management implications of FDG PET/CT in cutaneous malignant melanoma.
Falk MS; Truitt AK; Coakley FV; Kashani-Sabet M; Hawkins RA; Franc B
Nucl Med Commun; 2007 Apr; 28(4):273-80. PubMed ID: 17325590
[TBL] [Abstract][Full Text] [Related]
26. Diagnosis and treatment of cutaneous melanoma: state of the art 2006.
Garbe C; Eigentler TK
Melanoma Res; 2007 Apr; 17(2):117-27. PubMed ID: 17496787
[TBL] [Abstract][Full Text] [Related]
27. Review and current perspectives of cutaneous malignant melanoma.
Evans GR; Manson PN
J Am Coll Surg; 1994 May; 178(5):523-40. PubMed ID: 8167894
[No Abstract] [Full Text] [Related]
28. Epigenetic markers of prognosis in melanoma.
Sigalotti L; Fratta E; Parisi G; Coral S; Maio M
Methods Mol Biol; 2014; 1102():481-99. PubMed ID: 24258994
[TBL] [Abstract][Full Text] [Related]
29. New American Joint Commission on Cancer staging system for melanoma: prognostic impact and future directions.
Ross MI
Surg Oncol Clin N Am; 2006 Apr; 15(2):341-52. PubMed ID: 16632219
[TBL] [Abstract][Full Text] [Related]
30. Cutaneous melanoma in the elderly.
Testori A; Soteldo J; Sances D; Mazzarol G; Trifirò G; Zonta M; Rastrelli M; Schenone F; Verrecchia F
Melanoma Res; 2009 Jun; 19(3):125-34. PubMed ID: 19381113
[TBL] [Abstract][Full Text] [Related]
31. [Identification of the hereditary variants of skin melanoma].
Kazubskaia TP; Kozlova VM; Musatov VK; Mikhaĭlovskiĭ AV; Shabanov MA; Trofimov EI; Sel'chuk VIu; Gar'kavtseva RF
Genetika; 2004 Jan; 40(1):88-96. PubMed ID: 15027204
[TBL] [Abstract][Full Text] [Related]
32. [Clinical analysis of 42 cases of primary malignant melanoma in female genital tract].
An JS; Wu LY; Li N; Li B; Yu GZ; Liu LY
Zhonghua Fu Chan Ke Za Zhi; 2007 May; 42(5):320-4. PubMed ID: 17673044
[TBL] [Abstract][Full Text] [Related]
33. Pretreatment levels of peripheral neutrophils and leukocytes as independent predictors of overall survival in patients with American Joint Committee on Cancer Stage IV Melanoma: results of the EORTC 18951 Biochemotherapy Trial.
Schmidt H; Suciu S; Punt CJ; Gore M; Kruit W; Patel P; Lienard D; von der Maase H; Eggermont AM; Keilholz U; ;
J Clin Oncol; 2007 Apr; 25(12):1562-9. PubMed ID: 17443000
[TBL] [Abstract][Full Text] [Related]
34. [Study of the sentinel lymph node. Diagnosis and treatment of cutaneous malignant melanoma stages I and II].
Denninghoff V; Falco J; Curutchet HP; Elsner B
Medicina (B Aires); 2006; 66(2):144-6. PubMed ID: 16715764
[TBL] [Abstract][Full Text] [Related]
35. Melanocytic schwannoma of the cutaneous and subcutaneous tissues: three cases and a review of the literature.
Kaehler KC; Russo PA; Katenkamp D; Kreusch T; Neuber K; Schwarz T; Hauschild A
Melanoma Res; 2008 Dec; 18(6):438-42. PubMed ID: 19011514
[TBL] [Abstract][Full Text] [Related]
36. Expression of nm23-H1 in uveal melanoma.
Bakalian S; Marshall JC; Faingold D; Logan P; Antecka E; Burnier MN
Melanoma Res; 2007 Oct; 17(5):284-90. PubMed ID: 17885583
[TBL] [Abstract][Full Text] [Related]
37. Current status of biomarkers for melanoma metastasis.
Sondak VK; Messina JL
IDrugs; 2006 Sep; 9(9):627-31. PubMed ID: 16952070
[TBL] [Abstract][Full Text] [Related]
38. Serological and immunohistochemical analysis of S100 and new derivatives as markers for prognosis in patients with malignant melanoma.
Bolander A; Agnarsdóttir M; Wagenius G; Strömberg S; Pontén F; Ekman S; Brattström D; Larsson A; Einarsson R; Ullenhag G; Hesselius P; Bergqvist M
Melanoma Res; 2008 Dec; 18(6):412-9. PubMed ID: 19011512
[TBL] [Abstract][Full Text] [Related]
39. Update on therapy for melanoma: opportunities for patient selection and overcoming tumor resistance.
Koon HB; Atkins MB
Expert Rev Anticancer Ther; 2007 Jan; 7(1):79-88. PubMed ID: 17187522
[TBL] [Abstract][Full Text] [Related]
40. Lymphangiogenesis and its relationship with lymphatic metastasis and prognosis in malignant melanoma.
Liu B; Ma J; Wang X; Su F; Li X; Yang S; Ma W; Zhang Y
Anat Rec (Hoboken); 2008 Oct; 291(10):1227-35. PubMed ID: 18561194
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
